pyrazines has been researched along with guanosine monophosphate in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chikuma, M; Kalayda, GV; Komeda, S; Lutz, M; Reedijk, J; Sato, T; Spek, AL; Yamanaka, Y | 1 |
| Behera, I; Beigelman, L; Chaudhuri, S; Deval, J; Dyatkina, N; Jekle, A; Jin, Z; Kinkade, A; Rajwanshi, VK; Smith, DB; Symons, JA; Tucker, K; Wang, G | 1 |
| Allen, DM; Blasiak, A; Chai, LYA; Chan, CEZ; Chow, EK; Chye, H; Ho, D; Hooi, L; Lye, DCB; Remus, A; Seah, SGK; Tan, GG; Tan, SB; Truong, ATL; Wang, P; You, K | 1 |
3 other study(ies) available for pyrazines and guanosine monophosphate
| Article | Year |
|---|---|
New isomeric azine-bridged dinuclear platinum(II) complexes circumvent cross-resistance to cisplatin.
Topics: Animals; Antineoplastic Agents; Cisplatin; Crystallography, X-Ray; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Guanosine Monophosphate; Humans; Hydrogen-Ion Concentration; Ligands; Magnetic Resonance Spectroscopy; Mice; Platinum Compounds; Pyrazines; Pyridazines; Pyrimidines; Structure-Activity Relationship; Tumor Cells, Cultured | 2003 |
Structure-activity relationship analysis of mitochondrial toxicity caused by antiviral ribonucleoside analogs.
Topics: Adenosine; Amides; Antiviral Agents; Cell Line; Cytidine; DNA-Directed RNA Polymerases; Guanosine Monophosphate; Humans; Inhibitory Concentration 50; Mitochondria; Mitochondrial Proteins; Nucleosides; Prodrugs; Protein Biosynthesis; Pyrazines; Ribonucleosides; RNA; RNA, Mitochondrial; Sofosbuvir; Structure-Activity Relationship; Transcription Initiation Site; Transcription, Genetic | 2017 |
IDentif.AI-Omicron: Harnessing an AI-Derived and Disease-Agnostic Platform to Pinpoint Combinatorial Therapies for Clinically Actionable Anti-SARS-CoV-2 Intervention.
Topics: Amides; Artificial Intelligence; Auranofin; COVID-19 Drug Treatment; Guanosine Monophosphate; Humans; Phosphoramides; Pyrazines; SARS-CoV-2 | 2022 |